Tozasertib - CISMeF

Preferred Label : Tozasertib;

NCIt synonyms : n-(4-((4-(4-methylpiperazin-1-yl)-6-((5-methyl-1h-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide; Cyclopropanecarboxamide, n-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1h-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-;

UNII : 234335M86K;

InChIKey : GCIKSSRWRFVXBI-UHFFFAOYSA-N;

CAS number : 639089-54-6;

Chemical formula : C23H28N8OS;

Détails

Origin ID

C98053;

UMLS CUI

C3273787;

Currated CISMeF NLP mapping
- tozasertib [MeSH concept]
See also inter- (CISMeF)
- tozasertib [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- tozasertib [MeSH concept]
- tozasertib [MeSH Supplementary Concept]
chemical_or_drug_affects_gene_product
- Aurora Kinase A [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Tozasertib Lactate [NCIt concept]
has_target
- Aurora Kinase A [NCIt concept]
- Aurora Kinase B [NCIt concept]
- Aurora Kinase C [NCIt concept]
is_free_acid_or_base_form_of
- Tozasertib Lactate [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients